Adaptive Biotechnologies Corporation
ADPT
$15.77
-$0.35-2.17%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.62M | 9.59M | -25.61M | -29.85M | -33.61M |
| Total Depreciation and Amortization | 4.20M | 4.41M | 4.50M | 4.73M | 4.45M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.93M | 12.75M | 13.99M | 12.78M | 13.62M |
| Change in Net Operating Assets | -2.45M | -33.87M | -5.31M | -16.14M | 3.05M |
| Cash from Operations | 2.06M | -7.13M | -12.43M | -28.48M | -12.49M |
| Capital Expenditure | -636.00K | -409.00K | -655.00K | -1.26M | -80.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.62M | 17.69M | 4.00M | 26.83M | 22.20M |
| Cash from Investing | -8.25M | 17.28M | 3.35M | 25.57M | 22.12M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 21.66M | 1.68M | 1.61M | 5.45M | 127.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 21.66M | 1.68M | 1.61M | 5.45M | 127.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.46M | 11.84M | -7.47M | 2.54M | 9.76M |